Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The ability to modulate the volume of the future liver remnant is now a core and indispensable component of oncologic hepatobiliary surgery. Until recently there was general consensus that percutaneous portal vein embolization (PVE) represented the standard for safe and effective generation of future liver remnant hypertrophy.1,2 After PVE, the future remnant is exposed to increased portal flow and responds with a compensatory hypertrophy that reliably increases the safety of subsequent contralateral major hepatectomy.
Aloia TA. Associating Liver Partition and Portal Vein Ligation for Staged HepatectomyPortal Vein Embolization Should Remain the Gold Standard. JAMA Surg. 2015;150(10):927-928. doi:10.1001/jamasurg.2015.1646